Ferran Vall‐Llovera

758 total citations
12 papers, 132 citations indexed

About

Ferran Vall‐Llovera is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Ferran Vall‐Llovera has authored 12 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Ferran Vall‐Llovera's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ferran Vall‐Llovera is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ferran Vall‐Llovera collaborates with scholars based in Spain, Germany and United Kingdom. Ferran Vall‐Llovera's co-authors include Mar Tormo, Josep‐María Ribera, Jordi Esteve, Albert Oriol, José‐Ángel Hernández‐Rivas, Joan Bargay, Salut Brunet, David Valcárcel, Natalia Alonso and Rosa Coll and has published in prestigious journals such as Blood, Cancer and Oncotarget.

In The Last Decade

Ferran Vall‐Llovera

10 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferran Vall‐Llovera Spain 6 64 47 45 42 35 12 132
Yoshiaki Usui Japan 7 51 0.8× 36 0.8× 42 0.9× 38 0.9× 20 0.6× 22 119
Shane Gangatharan Australia 7 91 1.4× 66 1.4× 27 0.6× 54 1.3× 31 0.9× 19 135
Zoé Van de Wyngaert France 8 138 2.2× 68 1.4× 25 0.6× 81 1.9× 25 0.7× 22 191
Andrei Coliţă Romania 7 90 1.4× 24 0.5× 30 0.7× 31 0.7× 54 1.5× 38 153
Immacolata Attolico Italy 6 82 1.3× 44 0.9× 28 0.6× 27 0.6× 47 1.3× 17 146
Shlomzion Aumann Israel 7 53 0.8× 51 1.1× 24 0.5× 97 2.3× 33 0.9× 25 160
Naïs Prade France 5 42 0.7× 31 0.7× 29 0.6× 35 0.8× 37 1.1× 8 138
Betty Prine United States 5 40 0.6× 33 0.7× 40 0.9× 34 0.8× 51 1.5× 6 112
Alix Baugier de Materre France 8 40 0.6× 110 2.3× 99 2.2× 27 0.6× 45 1.3× 13 221
Camila Peña Chile 6 54 0.8× 36 0.8× 28 0.6× 43 1.0× 26 0.7× 43 111

Countries citing papers authored by Ferran Vall‐Llovera

Since Specialization
Citations

This map shows the geographic impact of Ferran Vall‐Llovera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferran Vall‐Llovera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferran Vall‐Llovera more than expected).

Fields of papers citing papers by Ferran Vall‐Llovera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferran Vall‐Llovera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferran Vall‐Llovera. The network helps show where Ferran Vall‐Llovera may publish in the future.

Co-authorship network of co-authors of Ferran Vall‐Llovera

This figure shows the co-authorship network connecting the top 25 collaborators of Ferran Vall‐Llovera. A scholar is included among the top collaborators of Ferran Vall‐Llovera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferran Vall‐Llovera. Ferran Vall‐Llovera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Molas, G, et al.. (2024). 4CPS-038 Case report on autonomic neuropathy induced by bortezomib. Section 4: Clinical pharmacy services. A69.2–A70.
2.
Pratcorona, Marta, Ana Garrido, Álex Bataller, et al.. (2023). Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort. Blood Cancer Journal. 13(1). 69–69. 9 indexed citations
3.
Pratcorona, Marta, Lurdes Zamora, Mònica López‐Guerra, et al.. (2022). RAS Mutations in Adult Acute Myeloid Leukemia (AML). Frequency, Mutational Spectrum, and Identification of a Comutation Bias for KRASK117 (TET2/ASXL1). Blood. 140(Supplement 1). 11821–11823. 1 indexed citations
4.
Malinverni, Roberto, Joan Bargay, Blanca Xicoy, et al.. (2021). Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival. Clinical Epigenetics. 13(1). 9–9. 23 indexed citations
5.
Bussaglia, Elena, Marta Pratcorona, Laura San‐Segundo, et al.. (2020). Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies). Annals of Hematology. 99(4). 765–772. 5 indexed citations
6.
Osorio, Santiago, Vicente Escudero‐Vilaplana, Ignacio Gómez‐Centurión, et al.. (2018). Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?. Annals of Hematology. 97(11). 2089–2098. 18 indexed citations
7.
Vall‐Llovera, Ferran, et al.. (2018). Neurological disorders induced by liposomal amphotericin B in hematological patients. 20(5). 274–276.
8.
9.
Steegmann, Juan Luis, Dolors Colomer, María Teresa Gómez‐Casares, et al.. (2017). An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase. Journal of Cancer Research and Clinical Oncology. 143(10). 2059–2066. 2 indexed citations
10.
Altés, Albert, Laia Paré, Albert Esquirol, et al.. (2013). Pharmacogenetic analysis in the treatment of Hodgkin lymphoma. Leukemia & lymphoma. 54(8). 1706–1712. 5 indexed citations
11.
Ribera, Josep‐María, Olga García, Carlos Grande, et al.. (2013). Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status. Cancer. 119(9). 1660–1668. 46 indexed citations
12.
Batlle, Montserrat, Ferran Vall‐Llovera, Jordi Bechini, et al.. (2007). Enterocolitis neutropénica en adultos con leucemia aguda o receptores de un trasplante de progenitores hematopoyéticos: estudio de 7 casos. Medicina Clínica. 129(17). 660–663. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiaki Usui Breakdown of academic impact, for papers by Shane Gangatharan Breakdown of academic impact, for papers by Zoé Van de Wyngaert Breakdown of academic impact, for papers by Andrei Coliţă Breakdown of academic impact, for papers by Immacolata Attolico Breakdown of academic impact, for papers by Shlomzion Aumann Breakdown of academic impact, for papers by Naïs Prade Breakdown of academic impact, for papers by Betty Prine Breakdown of academic impact, for papers by Alix Baugier de Materre Breakdown of academic impact, for papers by Camila Peña
Rankless by CCL
2026